Stakeholder engagement analysis - a bioethics dilemma in patient-targeted intervention: patients with temporomandibular joint disorders

Journal of Translational Medicine

Francesco Chiappelli¹  Angela Du¹  Mia Nguyen¹  Nateli Sama¹  Allison Jan¹  Gary Demerjian¹  Andre Barkhordarian¹ 

[1] Division of Oral Biology & Medicine, UCLA School of Dentistry, 10833 Le Conte Avenue, Los Angeles, CHS 63-090, CA, USA

关键词: Patient-targeted intervention;    Patient-evidence-provider fit;    Stakeholders engagement analysis;    Patient-centered outcomes research;    Temporomandibular joint disorders;    Translational science;    Bioethics;   

Others  :  1146196
DOI  :  10.1186/s12967-014-0366-z

 received in 2014-09-19, accepted in 2014-12-16,  发布年份 2015

【 摘 要 】

Modern health care in the field of Medicine, Dentistry and Nursing is grounded in fundamental philosophy and epistemology of translational science. Recently in the U.S major national initiatives have been implemented in the hope of closing the gaps that sometimes exist between the two fundamental components of translational science, the translational research and translational effectiveness. Subsequent to these initiatives, many improvements have been made; however, important bioethical issues and limitations do still exist that need to be addressed. One such issue is the stakeholder engagement and its assessment and validation. Federal, state and local organizations such as PCORI and AHRQ concur that the key to a better understanding of the relationship between translational research and translational effectiveness is the assessment of the extent to which stakeholders are actively engaged in the translational process of healthcare. The stakeholder engagement analysis identifies who the stakeholders are, maps their contribution and involvement, evaluates their priorities and opinions, and accesses their current knowledge base. This analysis however requires conceptualization and validation from the bioethics standpoint. Here, we examine the bioethical dilemma of stakeholder engagement analysis in the context of the person-environment fit (PE-fit) theoretical model. This model is an approach to quantifying stakeholder engagement analysis for the design of patient-targeted interventions. In our previous studies of Alzheimer patients, we have developed, validated and used a simple instrument based on the PE-fit model that can be adapted and utilized in a much less studied pathology as a clinical model that has a wide range of symptoms and manifestations, the temporomandibular joint disorders (TMD). The temporomandibular joint (TMJ) is the jaw joint endowed with sensory and motor innervations that project from within the central nervous system and its dysfunction can be manifested systemically in forms of movement disorders, and related pathological symptomatologies.

Currently, there is limited reliable evidence available to fully understand the complexity of the various domains of translational effectiveness, particularly in the context of stakeholder engagement and its assessment, validation as well as the bioethical implications as they pertain to evidence-based, effectivness-focused and patient-centered care.

【 授权许可】

   
2015 Barkhordarian et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]US Government Publishing Office. Public Law 111-148-The Patient Protection and Affordable Care Act. 2010. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed 14 Oct 2014.
• [2]Chiappelli F: Fundamentals of Evidence-Based Health Care and Translational Science. Springer-Verlag, Heidelberg, DE; 2014.
• [3]Alomar X, Medrano J, Cabratosa J, Clavero JA, Lorente M, Serra I, et al.: Anatomy of the temporomandibular joint. Semin Ultrasound CT MR. 2007, 28:170-83.
• [4]Pritchard TE, Alloway D: Medical neuroscience. Hayes Barton Press, Raleigh, NC; 1999.
• [5]Sims AB, Stack BC, Demerjian GG: Spasmodic torticollis: the dental connection. Cranio. 2012, 30:188-93.
• [6]Barkhordarian A, Ajaj R, Ramchandani MH, Demerjian G, Cayabyab R, Danaie S, Ghodousi N, Iyer N, Mahanian N, Phi L, Giroux A, Manfrini E, Neagos N, Siddiqui M, Cajulis OS, Brant X, Shapshak P, Chiappelli F: Osteoimmunopathology in HIV/AIDS. A Translational Evidence-Based Perspective. Pathology Research International, 2011, Article ID 359242 epub 21 May 2011.
• [7]Demerjian GG, Sims AB, Stack BC: Proteomic signature of Temporomandibular Joint Disorders (TMD): Toward diagnostically predictive biomarkers. Bioinformation. 2011, 5:282-4.
• [8]Barkhordarian A, Demerjian G, Chiappelli F. Systemic correlates and local responses to Temporomandibular Joint Disorders. 94th AAAS-PD Annual Meeting, Las Vegas, NV; 15–19 June 2013.
• [9]Wu RC, Tran K, Lo V, O’Leary KJ, Morra D, Quan SD, et al.: Effects of clinical communication interventions in hospitals: a systematic review of information and communication technology adoptions for improved communication between clinicians. Int J Med Inform. 2012, 81:723-32.
• [10]Goodman SN, Gerson J. Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013. Jun. AHRQ Methods for Effective Health Care Report No: 13-EHC042-EF.
• [11]Chiappelli F: The Patient-Centered Dental Home Model. Dental Hypotheses. 2011, 2:105-12.
• [12]Arend J, Tsang-Quinn J, Levine C, Thomas D: The patient-centered medical home: history, components, and review of the evidence. Mt Sinai J Med. 2012, 79:433-50.
• [13]Freeman R, Edward R, Reed DL: Stockholders and Stakeholders: A new perspective on Corporate Governance. Calif Manag Rev. 1983, 25:88-106.
• [14]Qian M, Wu D, Wang E, Marincola FM, Wang W, Rhodes W, et al.: Development and promotion in translational medicine: Perspectives from 2012 sino-american symposium on clinical and translational medicine. Clin Trans Med. 2010, 1:25-30. BioMed Central Full Text
• [15]Deverka PA, Lavallee DC, Desai PJ, Esmail LC, Ramsey SD, Veenstra DL, et al.: Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. J Comparative Effect Res. 2012, 1:181-94.
• [16]de Almeida Moura J, Carvalho Costa B, de Faria RMD, Figueiredo Soares T, Perlatto Moura E, Chiappelli F: Improving communication skill training in patient centered medical practice for enhancing rational use of laboratory tests: The core of bioinformation for leveraging stakeholder engagement in regulatory science. Bioinformation. 2013, 9:718-20.
• [17]Fletcher A, Guthrie J, Steane P, Roos G, Pike S: Mapping stakeholder perceptions for a third sector organization. J Intellect Cap. 2003, 4:505-27.
• [18]Aarons GA, Wells RS, Zagursky K, Fettes DL, Palinkas LA: Implementing Evidence-Based Practice in Community Mental Health Agencies: A Multiple Stakeholder Analysis. Am J Public Health. 2009, 99:2087-95.
• [19]Strauss ME, Smith GT: Construct Validity: Advances in Theory and Methodology. Annu Rev Clin Psychol. 2009, 5:1-25.
• [20]Shavelson RJ, Webb NM: Generalizability Theory: 1973–1980. Br J Math Stat Psychol. 1981, 34:133-66.
• [21]French JRP Jr, Rodgers WL, Cobb S: Adjustment as person-environment fit. In Coping and adaptation. Edited by Coelho G, Hamburg D, Adams J. Basic Books, New York; 1974:316-33.
• [22]Caplan RD, Harrison RV: Person-environment fit theory: Some history, recent developments, and future directions. J Soc Issues. 1993, 49:253-75.
• [23]Edwards JR, Caplan RD, Harrison RV: Person-environment fit theory: Conceptual foundations, empirical evidence, and directions for future research. In Theories of organizational stress. Edited by Cooper CL. Oxford University Press, Oxford, GB; 1998:28-67.
• [24]Edwards JR, Cooper CL: The person-environment fit approach to stress: Recurring problems and some suggested solutions. J Organ Behav. 1990, 11:293-307.
• [25]Chiappelli F, Manfrini E, Edgerton M, Rosenblum M, Kristine D, Cajulis KD, et al.: Clinical Evidence and Evidence-Based Dental Treatment of Special Populations: Patients with Alzheimer’s Disease. California Dental Assoc J. 2006, 34:439-47.
• [26]Loughlin M, Bluhm R, Drozdstoj S, Stoyanov DS, Buetow S, Upshur REG, et al.: Explanation, understanding, objectivity and experience. J Eval Clin Pract. 2013, 19:415-21.
• [27]Maglo KN: Group-Based and Personalized Care in an Age of Genomic and Evidence-Based Medicine: A Reappraisal. Perspect Biol Med. 2012, 55:137-54.
• [28]Petrini C: Ethical Issues in Translational Research. Perspect Biol Med. 2010, 53:517-33.
• [29]de Melo-Martín I, Intemann K: Interpreting Evidence: Why Values Can Matter As Much As Science. Perspect Biol Med. 2012, 55:59-70.
• [30]Barkhordarian A, Ramchandani MH, Dousti M, Kelly-Gleason L, Chiappelli F: Disseminating the best available evidence: New challenges in public reporting of health care. Bioinformation. 2012, 8:293-5.